1. Nerenstone SR, Inde DC, Friedman MA. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev. 1988; 15:1–31.
2. Ohnishi K, Tanabe Y, Ryu M, Isono K, Yamamoto Y, Usui S, Hiyama Y, Goto N, Iwama S, Sugita S, Nomura F, Okuda K. Prognosis of HCC smaller than 5 cm in relation to treatment: Study of 100 patients. Hepatology. 1987; 7:1285–90.
3. Shepherd FA, Rotstein L, Blackstein ME, Burkes R, Erlichman C, Iscoe N, Kutas G, Paul K, Mah P. Treatment of primary HCC by hepatic arterial infusion of 4’-epirubicin. Reg Cancer Treat. 1990; 3:197–201.
4. O’Connell MJ, Hahn RG, Rubin J, Moertel CG. Chemotherapy of malignant hepatomas with sequential intra-arterial doxorubicin and systemic 5-fluorouracil and semustine. Cancer. 1988; 62:1041–3.
5. Kanematsu T, Furuta T, Takenaka K, Matsumata T, Yoshida Y, Nishizaki T, Hasuo K, Sugimachi K. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with HCC. Hepatology. 1989; 10:98–102.